| Title | Association between inflammatory markers and disease severity assessment in psoriatic patients treated with etanercept | ||
| Authors | A. Kanelleas1, C. Liapi2, A. Grafakos1, K. Theodoropoulos1, D. Pantelis1, T. Economopoulos3 and N. G. Stavrianeas1
1. Second Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, Attikon University General Hospital, Athens, Greece 2. Department of Pharmacology, National and Kapodistrian University of Athens, Medical School 3. Second Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Attikon University General Hospital, Athens, Greece |
||
| Citation | Kanelleas, A., Liapi, C., Grafakos, K., Theodoropoulos K., Pantelis, D. et al.: Association between inflammatory markers and disease severity assessment in psoriatic patients treated with etanercept, Epitheorese Klin. Farmakol. Farmakokinet. 24(2): 151-152 (2010) | ||
| Publication Date | 2010 | ||
| Full Text Language | English | ||
| Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)
pharmakonpress[at]pharmakonpress[.]gr |
||
| Keywords | Psoriasis, inflammation, Etanercept, treatment. | ||
| Other Terms | Review article | ||
| Summary | Psoriasis is a common, inflammatory, chronic skin disease. Its precise aetiology is unknown. Immunological responses via T-cell activation as well as a cascade of inflammatory reactions play a central role in its pathogenesis. We measured an array of inflammatory markers in psoriatic patients at baseline and after twelve weeks of Etanercept treatment. Statistical analysis suggested that there might be an association between disease severity assessments, as this is clinically described by PASI, and inflammatory markers (fibrinogen at baseline and hs-CRP at the end of treatment). | ||
| References | 1. Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
2. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873. 3. Nickoloff BJ. Cracking the cytokine code in psoriasis. Nat Med 2007; 13: 242-4. 4. Pathirana D, Ormerod AD, Saiag P et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (suppl 2): 34-8 |
||
| Relative Papers | |||
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
| ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2010 – ANNUAL SUBSCRIPTION 2010 | |
| Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
| Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr |
| Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr |
|